BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Ablynx Will Host a Webcast to Discuss Additional Data From its Phase III Hercules Study of Caplacizumab in Acquired TTP Following ASH Late-Breaking Data Presentation

  The late-breaking data presentation will include positive topline results from the Phase III HERCULES study of caplacizumab announced on 2 October 2017 together with important data from additional analyses on the use of plasma exchange.

  December 7, 2017

   · 

  5 min read
• ABIVAX to Present in Plenary Session at the 8th International Conference on HIV Persistence During Therapy

  The conference will take place December 12-15 at the Marriott Biscayne Bay Resort in Miami, FL.

  December 7, 2017

   · 

  1 min read
• EOS Imaging Awarded ihe Prix Galien in ihe Medical Device Category

  EOS Imaging today announced the Galien Foundation has awarded it the Prix Galien in the Medical Device category.

  December 7, 2017

   · 

  2 min read
• Technial University of Munich Release: DNA Origami Surpasses Important Thresholds

  Now Dietz and his team have not only broken out of the nanometer realm to build larger objects, but have also cut the production costs a thousand-fold.

  December 7, 2017

   · 

  5 min read
• Biotech Beach

  US Compounding, a Subsidiary of Adamis Pharmaceuticals, Develops a Unique Compound to Manage Ulcers in Horses

  A study, utilizing US Compounding’s unique drug formulation, was conducted in approximately 50 race horses.

  December 7, 2017

   · 

  4 min read
• Pluristem to Present Data on PLX-R18 in Treatment of Acute Radiation Syndrome at ASH’s Annual Meeting

  The results of the study will be presented during Program Session 506: Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells.

  December 7, 2017

   · 

  5 min read
• Business

  Analogic Announces Results for the First Quarter Ended October 31, 2017 and Declares Quarterly Cash Dividend

  Revenue of $106.9 million with gross margin of 45%.

  December 7, 2017

   · 

  12 min read
• Business

  WishBone Medical Names Jean-Pierre Capdevielle as Chief Strategy Officer and Board Member

  Mr. Capdevielle is a seasoned executive with over 37 years of international experience and has a successful track record of helping startup companies.

  December 7, 2017

   · 

  3 min read
• Drug Development

  Novartis Kisqali is First and Only CDK4/6 Inhibitor to Show Superior Median PFS Compared to Oral Endocrine Therapy as First-Line Treatment in a Prospective, Randomized Phase III Trial

  Kisqali is the only CDK4/6 inhibitor to show efficacy in combination with tamoxifen.

  December 7, 2017

   · 

  14 min read
• Drug Development

  Immunomedics Announces Updated Results With Sacituzumab Govitecan (IMMU-132) in Patients With Relapsed or Refractory Metastatic Triple-Negative Breast Cancer (mTNBC)

  The independent centrally-reviewed (ICR) median DOR was 9.1 months. These efficacy data are summarized in the table below.

  December 7, 2017

   · 

  6 min read